Fundamentals

Valuation

Metric	Q4	Q2	Δ in %
EV/EBITDA	-64.40	19.27	54.13
Graham Fair Price	108.36	0.66	0.31
PEG	-100.00	-0.04	0.00
Price/Book	6.88	1.02	0.96
Price/Cash Flow	-85.87	11.03	-78.07
Prices/Earnings	-74.54	12.78	-50.20
Price/Sales	-48.61	1.29	2.51
Price/FCF	-85.87	11.03	-78.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q2	Δ in %
Gross Profit Margin	30.51	0.12	0.10
Operating Margin	185.92	0.03	< 0.005
ROA	329.85	< 0.005	< 0.005
ROE	< 0.005	0.02	319.76
ROIC	< 0.005	0.02	822.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q2	Δ in %
Debt QOQ	-0.10	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	3.63	100.00
EPS QOQ	0.00	3.13	100.00
FCF QOQ	0.00	7.43	100.00
Revenue QOQ	0.00	0.06	100.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	70.46	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.49	0.21	-56.93
Quick Ratio	0.71	2.12	196.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q2	Δ in %
Book Value	0.96	0.98	1.70
Cash	0.28	0.35	26.27
Capex	-0.02	-0.02	7.76
Free Cash Flow	-0.01	0.09	669.40
Revenue	0.37	0.77	111.49
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q2	Δ in %
Current Ratio	2.34	2.13	-9.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	22.67	6.47	-71.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating